How health risks of the NuvaRing disappeared from the graphs

The Dutch pharmaceutical company Organon left crucial data that pointed at increased health risks out of their research findings of birth control product Nuvaring. Also, the company did everything [possible] to minimize the risks of thrombosis in the ‘enclosed’ pamphlet accompanying the product. This shows up in the documents in possession of ‘De Correspondent’ a Dutch on-line investigative blog post.  Read the translation of the post by clicking here.

This entry was posted in Adverse Events, Blood Clots, DVT, FDA, Pulmonary Embolism and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s